Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Urothelial carcinoma of the upper urinary tract diagnosed via FGFR3 mutation detection in urine: a case report.

BMC urology - 8 Aug 2012

Silverberg Daniel M

Abstract excerpt

BACKGROUND: Upper urinary tract cancer is typically diagnosed with urine cytology and imaging techniques. These assays can be limited by sensitivity, specificity, or technical issues making some diagnoses difficult. CASE PRESENTATION: A 73-year old man presented to the clinic with a right renal p...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers
Share to FGFR3 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Receptor, Fibroblast Growth Factor, Type 3

Share to Urologic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 22873290
DOI: 10.1186/1471-2490-12-20
PMCID: PMC3465177

Genes

FGFR3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22873290-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Urothelial carcinoma of the upper urinary tract diagnosed via FGFR3 mutation detection in urine: a case report.PMID 22873290Read ↗

Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detectionSemantic proximity Read ↗

Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine.Semantic proximity Read ↗

Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target.Semantic proximity Read ↗

Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencingSemantic proximity Read ↗

A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine.Semantic proximity Read ↗

Optimization of nonmuscle invasive bladder cancer recurrence detection using a urine based FGFR3 mutation assay.Semantic proximity Read ↗

FGFR3 Mutations in Urothelial Carcinoma: A Single-Center Study Using Next-Generation SequencingSemantic proximity Read ↗

Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma.Semantic proximity Read ↗

Reflex somatic testing for the detection of FGFR alterations in urinary tract carcinomas: A dual-institutional experience.Semantic proximity Read ↗

[Preliminary study of p53 and FGFR3 gene mutations in the urine for bladder tumors].Semantic proximity Read ↗

Diagnostic potential of TERT promoter and FGFR 3 mutations in urinary cell‐free DNA in upper tract urothelial carcinomaSemantic proximity Read ↗

Urine cytology suspicious for urothelial carcinoma: Prospective follow-up of cases using cytology and urine biomarker-based ancillary techniques.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.